Pathway to Independence Award in Cancer Nanotechnology Research (K99/R00)

The summary for the Pathway to Independence Award in Cancer Nanotechnology Research (K99/R00) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pathway to Independence Award in Cancer Nanotechnology Research (K99/R00): Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits applications for the Pathway to Independence Award (K99/R00) in Cancer Nanotechnology Research. This initiative is an integral component of a broader program to continue the interactive NCI Alliance for Nanotechnology in Cancer (the Alliance) (http://nano.cancer.gov). In addition to this initiative, the Alliance will consist of the Center for Nanotechnology Excellence (CCNEs, as a core of the program infrastructure), platform projects (CNPPs), and Cancer Nanotechnology Training Centers (CNTCs). The primary purpose of this Pathway to Independence Award Program is to increase and maintain a strong cohort of new talented investigators focused on research in cancer nanotechnology. The program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent research support at an earlier stage than is currently the norm. Mechanism of Support. This FOA will utilize the NIH Pathway to Independence Award (K99/R00) mechanism. This FOA complements other Alliance FOAs that will support the Centers for Cancer Nanotechnology Excellence awards (U54 funding mechanism, RFA-CA-09-012), the Cancer Nanotechnology Platform Partnerships (U01 mechanism, RFA-CA-09-013), and Cancer Nanotechnology Training Centers (R25 mechanism, RFA-CA-09-014). Funds Available and Anticipated Number of Awards. For this K99/R00 FOA, the NCI has committed approximately $2 million in total costs for FY 2010 and $10 million over a 5-year period. Approximately 8-10 awards are expected to be made in connection with this FOA.
Federal Grant Title: Pathway to Independence Award in Cancer Nanotechnology Research (K99/R00)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-09-015
Type of Funding: Grant
CFDA Numbers: 93.393
CFDA Descriptions: Cancer Cause and Prevention Research
Current Application Deadline: Dec 17, 2009
Original Application Deadline: Dec 17, 2009
Posted Date: Oct 08, 2009
Creation Date: Oct 08, 2009
Archive Date: Jan 17, 2010
Total Program Funding: $2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Regional Organizations; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer ...
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Cli...
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U0...
Pilot Studies in Pancreatic Cancer
Cancer Prevention Research Small Grant Program
Molecular Targets for Nutrients in Prostate Cancer Prevention
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com